Edition:
United Kingdom

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

3.61USD
23 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.61
Open
$3.56
Day's High
$3.62
Day's Low
$3.52
Volume
12,556
Avg. Vol
239,478
52-wk High
$5.82
52-wk Low
$1.59

Select another date:

Mon, Apr 16 2018

BRIEF-HTG Promotes John Lubniewski To President And Chief Operating Officer

* HTG PROMOTES JOHN LUBNIEWSKI TO PRESIDENT AND CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work

* HTG MOLECULAR DIAGNOSTICS INC - ON MARCH 30, 2018, CO AND QIAGEN MANCHESTER LIMITED ENTERED SECOND AMENDMENT OF FIRST STATEMENT OF WORK - SEC FILING

BRIEF-Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial

* HTG MOLECULAR DIAGNOSTICS SECURES DEBT FACILITY WITH MIDCAP FINANCIAL

BRIEF-HTG Molecular Q4 Loss Per Share $0.15

* HTG MOLECULAR DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

BRIEF-Stonepine Capital Management Reports 5.6 Pct Passive Stake In HTG Molecular Diagnostics

* STONEPINE CAPITAL MANAGEMENT LLC REPORTS A 5.6 PERCENT PASSIVE STAKE IN HTG MOLECULAR DIAGNOSTICS INC AS OF JANUARY 19 - SEC FILING Source text - http://bit.ly/2G2Dlxg Further company coverage:

BRIEF-HTG Molecular Diagnostics Expects Q4 2017 Revenue of $7.6 Mln to $7.9 Mln- SEC Filing

* HTG MOLECULAR DIAGNOSTICS SAYS BASED ON CURRENTLY AVAILABLE INFORMATION EXPECTS Q4 2017 REVENUE BETWEEN $7.6 MILLION AND $7.9 MILLION - SEC FILING Source text: (http://bit.ly/2D99dyn) Further company coverage:

BRIEF-HTG Molecular Announces Third Statement Of Work For New Clinical Assay Development Program

* HTG MOLECULAR ANNOUNCES THIRD STATEMENT OF WORK FOR NEW CLINICAL ASSAY DEVELOPMENT PROGRAM

BRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement

* HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT

BRIEF-HTG Molecular Diagnostics Expands Its Collaboration With Merck

* HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY

Select another date: